期刊文献+

上皮性卵巢癌中PTEN和Ki-67的表达及意义 被引量:3

Expression and significance of pten and KI-67 in ovarian epithelial carcinoma
下载PDF
导出
摘要 目的 探讨上皮性卵巢癌中PTEN和Ki- 6 7的蛋白表达及意义。方法 采用免疫组织化学S -P法检测了 6 4例上皮性卵巢癌 ,30例卵巢良性肿瘤和 2 0例正常卵巢组织中PTEN和Ki- 6 7的蛋白表达。分析PTEN和Ki- 6 7的蛋白表达及其与各种临床病理参数、预后的关系及二者的相关性。结果 在上皮性卵巢癌组织中PTEN蛋白的阳性率明显低于正常卵巢组织和卵巢良性肿瘤组织。PTEN蛋白在病理分化差的G3组阳性率明显低于分化较好的G1-G2组 ;在临床Ⅲ~Ⅳ期组PTEN蛋白阳性率明显低于临床Ⅰ~Ⅱ期组。而Ki- 6 7在以上各组的阳性率与PTEN蛋白阳性率相比恰好相反。PTEN和Ki- 6 7蛋白的阳性率与年龄、组织类型均无关。在上皮性卵巢癌中 ,PTEN与Ki- 6 7的蛋白表达呈负相关 (r=- 0 5 94 )。患者的生存时间与PTEN蛋白阳性率呈正相关 ,与Ki- 6 7阳性率呈负相关。结论 PTEN蛋白在上皮性卵巢癌中表达明显低于正常及良性肿瘤组织 ,提示PTEN的缺失与卵巢癌的发生、发展有关 ;PTEN、Ki- 6 7阳性率与上皮性卵巢癌的病理分化、临床分期和生存时间有关 ,提示PTEN蛋白表达的缺失和减少导致细胞增殖的增加 ,预示着卵巢癌的不良预后。 Objective To investigate the expression of PTEN and Ki-67 in ovarian epithelial carcinoma and their relationship with clinicopathologic factors and prognosis.Methods The expression of PTEN and Ki-67 in 64 cases of ovarian epithelial cancer, 30 benign tumors and 20 normal ovarian tissue were determined by S-P immunohistochemical method.Results The positive rate of PTEN in the ovarian cancer tissue was lower than in the normal and benign ovarian tissues. The expression level of PTEN in stage Ⅲ~Ⅳ group was lower than that of stage Ⅰ~Ⅱ group (P<0.05); in poorly differentiated cancer (G3) was lower than well differentiated (G1-G2). Ki-67 expression trend was opposite to that of PTEN. No different expression of PTEN and Ki-67 among histological types or ages was found. In the ovarian cancer, negative correlation between expression of PTEN and Ki-67 was observed (r=-0.594). In univariate analysis, the expression of PTEN and Ki-67 were associated with survival rate. Conclusions PTEN expression in ovarian cancer was down-regulated. The expression level of PTEN and Ki-67 were associated with differentiation, clinic stage and survival. The relationship between PTEN and Ki-67 suggests that PTEN may suppress the tumor through down-regulate cell proliferation.
出处 《中国妇产科临床杂志》 2004年第5期370-373,377,共5页 Chinese Journal of Clinical Obstetrics and Gynecology
  • 相关文献

参考文献13

  • 1[1]Ali IU, Schriml LM, Dean M, et al. Mutational spectra of PTEN/ MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl CancerInst, 1999, 91: 1922-1932.
  • 2[2]Tashiro H, Blazes MS, Wu R, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res, 1997, 57:3935 - 3940.
  • 3[3]Kurose K, Zhou XP, ArakiT, etal. Frequent loss of PTENexpression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol, 2001, 158: 2097-2106.
  • 4[4]Obata K, Morland SJ, Wateon RH, et al. Frenquent PTEN/MMAC1mutations in endomerioid but not serous or mucinous epithelial ovarian tummors. Cancer Res, 1998, 58: 2095-2097.
  • 5车艳辞,姚勤,戴淑真.上皮性卵巢癌PTEN蛋白表达分析[J].中国实用妇科与产科杂志,2002,18(6):349-350. 被引量:2
  • 6屈洪涛,刘运生,肖亚飞,梁有明.胶质母细胞瘤PTEN基因突变和ki-67表达的研究[J].中国现代医学杂志,2003,13(8):37-39. 被引量:6
  • 7[7]Li J, Yen C, Liaw D, et al. PTEN, a putative protein ryrosine phos phatase gene mutated in human brain, breast and prostate cancer. Science, 1997, 275: 1876- 1879, 1943 - 1947.
  • 8[8]Steck PA,PershouseMA,Jasser SA,et al.Identification of a candidate tumor suppressor gene,MMACI,at chromosom 10 q23.3that is mutat ed in multiple advanced cancer.Nat Genet,1997,15:356-362.
  • 9[9]LiDM,Sun H.Tepl,encoded by a candidate tumor suppressorlocus,is a novalprotein tyrosine phosphatase regulated by transforming growth factorβ.Cancer Res,1997,57:2124-2130.
  • 10[10]Sakurada A,Suzuki A,Sato M,et al.Infrequent genetic alterations of thePTEN/MMAC1 gene in Japanese patients with primary cancer of the breast,lung,pancreas,kidney,and ovary.Jpn J Cancer Res,1997, 88: 1025-1028.

二级参考文献22

  • 1[1]Tashiro H,Blazes MS,Wu R,et al.Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.Cancer Res,1997,57(18):3935
  • 2[2]Obata K,Morland SJ,Watson RH,et al.Frequent PTEN/MMAC1 mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.Cancer Res,1998,58(10):2095
  • 3[3]Sato N,Tsunoda H,Nishida M.Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary:possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.Cancer Res,2000,60(24):7052
  • 4[4]Minaguchi T,Mori T,Kanamori Y,et al.Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene.Cancer Res,1999,59(24):6063
  • 5Sano T, Lin H, Chen X, et al. Differential expression of MMAC/PTEN in glioblastoma multfforme : relationship to localization and prognosis. Cancer Res, 1999;59:1820.
  • 6Davies MPA, Gibbs FEM, Halliwell N, et al. Mutation in the PTEN/MMAC 1 gene in archival low grade and high grade gliomata. Brifish Journal of Cancer, 1999;79(9/10) : 1542.
  • 7Stek PA, Pershouse MA,Jasser SA, et al. Identification of a candidate turnout suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet, 1997; 15:356.
  • 8Tamura M, Gu J, Takino T, et al. Tumor suppremor PTEN inhibition of cell invasion,migration, and growth: differtmtial involvement of focal adhesion kinase and p130cas. Cancer Res, 1999;59:442.
  • 9Cheney IW, Johnson DE, Vaillancourt MT, et al. Suppression of tumorigenicity of glioblastoma cells by adenovims - mediated MMAC1/FrFEN gene transfer. Cancer Res, 1998;58:2331.
  • 10Chiariello E,Roz L,Albarosa R, et al. PTEN/MMAC1 mutations in primary glioblastomas and short - term cultures of malignant gliomata. Oncogene, 1998; 16:541.

共引文献24

同被引文献17

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部